These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7299672)

  • 21. Cooperative lipid-protein interaction. Effect of pH and ionic strength on polymyxin binding to phosphatidic acid membranes.
    Sixl F; Galla HJ
    Biochim Biophys Acta; 1979 Nov; 557(2):320-30. PubMed ID: 40598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the influence of media composition and ionic strength on drug release from commercial immediate-release and enteric-coated aspirin tablets.
    Karkossa F; Klein S
    J Pharm Pharmacol; 2017 Oct; 69(10):1327-1340. PubMed ID: 28703304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexation of buffer constituents with neutral complexation agents: part I. Impact on common buffer properties.
    Riesová M; Svobodová J; Tošner Z; Beneš M; Tesařová E; Gaš B
    Anal Chem; 2013 Sep; 85(18):8518-25. PubMed ID: 23889602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of hemolysis buffer structure, pH and ionic strength to spontaneous contour smoothing of isolated erythrocyte membranes.
    Raval PJ; Carter DP; Fairbanks G
    Biochim Biophys Acta; 1989 Aug; 983(2):230-40. PubMed ID: 2758059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatographic study of interactions between polyvinylpyrrolidone and drugs.
    Horn D; Ditter W
    J Pharm Sci; 1982 Sep; 71(9):1021-6. PubMed ID: 7131267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients.
    Austin RP; Barton P; Davis AM; Manners CN; Stansfield MC
    J Pharm Sci; 1998 May; 87(5):599-607. PubMed ID: 9572911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutions.
    Reubsaet JL; Beijnen JH; Bult A; van der Houwen OA; Teeuwsen J; Koster EH; Underberg WJ
    Anal Biochem; 1995 May; 227(2):334-41. PubMed ID: 7573955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation kinetics of a substituted carbinolamine in aqueous media.
    Maulding HV; Zoglio MA
    J Pharm Sci; 1977 Aug; 66(8):1175-80. PubMed ID: 19617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics.
    Grit M; Zuidam NJ; Underberg WJ; Crommelin DJ
    J Pharm Pharmacol; 1993 Jun; 45(6):490-5. PubMed ID: 8103093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The formulation of buffers and media for enzyme histochemistry.
    Clancy MJ
    Histochem J; 1987 Jan; 19(1):27-34. PubMed ID: 3583813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of pH and temperature on the degradation kinetics of 4-methoxy-2-[3-(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c] pyridine in aqueous solutions.
    Muszalska I; Wituła K
    Acta Pol Pharm; 2005; 62(2):83-8. PubMed ID: 16161346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solution stability of ciclosidomine.
    Carney CF
    J Pharm Sci; 1987 May; 76(5):393-7. PubMed ID: 3656101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative and qualitative optimization of allergen extraction from peanut and selected tree nuts. Part 2. Optimization of buffer and ionic strength using a full factorial experimental design.
    L'Hocine L; Pitre M
    Food Chem; 2016 Mar; 194():820-7. PubMed ID: 26471623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of povidone with aromatic compounds V: Relationship of binding tendency in a macromolecular solution treated as a pseudo two phase and a monophase.
    Plaizier-Vercammen JA
    J Pharm Sci; 1984 Dec; 73(12):1774-9. PubMed ID: 6527254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of Zwitterion-based solutions to dissect the relative effects of solution pH and ionic strength on the aggregation behavior and conformational stability of a fusion protein.
    Zhou R; Nashine V; Palm T; Gandhi R; Adams M
    J Pharm Sci; 2014 Oct; 103(10):3065-74. PubMed ID: 25139470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody.
    Roberts D; Keeling R; Tracka M; van der Walle CF; Uddin S; Warwicker J; Curtis R
    Mol Pharm; 2015 Jan; 12(1):179-93. PubMed ID: 25389571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of ionic strength effects: interaction of enzyme and sulfate ion in CO2 hydration and HCO3- dehydration reactions catalyzed by carbonic anhydrase II.
    Pocker Y; Miao CH
    Biochemistry; 1987 Dec; 26(25):8481-6. PubMed ID: 3126803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of NADH stability using ultraviolet-visible spectrophotometric analysis and factorial design.
    Rover Júnior L; Fernandes JC; de Oliveira Neto G; Kubota LT; Katekawa E; Serrano SH
    Anal Biochem; 1998 Jun; 260(1):50-5. PubMed ID: 9648652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retention behaviour of acidic, neutral and basic drugs on a CN column using phosphate buffers in the mobile phase.
    De Smet M; Massart DL
    J Chromatogr; 1987 Nov; 410(1):77-94. PubMed ID: 3429557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.